PharmaCyte Biotech, Inc. insider trading
PMCB$0.39-0.01 (-2.50% today)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-62.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Unlock quarterly net flowKey players
- JSJoshua Silverman4.343%
- JSJonathan Schechter1.7931%
- RWRobert Weinstein0.3842%
- MMMichael M. Abecassis0.2151%
- WRWayne Remell Walker0.1921%
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| PMCB | Joshua Silverman | Open market purchase$33.2K | +9.4% | $0.83 | $33.2K | Jan 7, 2026 | Jan 7, 2026 |
| PMCB | Jonathan Schechter | Open market purchase$16.8K | +11.6% | $0.84 | $16.8K | Jan 7, 2026 | Jan 7, 2026 |
| PMCB | Joshua Silverman | Open market purchase$23.7K | +7.6% | $0.79 | $23.7K | Jan 6, 2026 | Jan 7, 2026 |
| PMCB | Jonathan Schechter | Open market purchase$15.8K | +13.1% | $0.79 | $15.8K | Jan 6, 2026 | Jan 7, 2026 |
| PMCB | Joshua Silverman | Open market purchase$23.4K | +8.2% | $0.78 | $23.4K | Jan 5, 2026 | Jan 7, 2026 |
| PMCB | Jonathan Schechter | Open market purchase$15.6K | +15.1% | $0.78 | $15.6K | Jan 5, 2026 | Jan 7, 2026 |